Erratum: Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/ progenitor cells with 5-aza-29-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis (J. Biol. Chem. (2012) 287:47 (39954-39966) DOI: 10.1074/jbc.M112.395574);Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2′-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis

Journal of Biological Chemistry

Volumn 287, Issue 47, 2012, Pages 39954-39966

  Tian, Jing ^a,b   Lee, Soo Ok ^b   Liang, Liang ^b,c   Luo, Jie ^b   Huang, Chiung Kuei ^b   Li, Lei ^b,c   Niu, Yuanjie ^a   Chang, Chawnshang ^b,d  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c XI'AN JIAOTONG UNIVERSITY   (China)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATION; CELL CULTURE; DIGITAL STORAGE; METHYLATION; STEM CELLS; UROLOGY;

ANDROGEN RECEPTORS; BINDING PROTEINS; IN-VITRO ASSAYS; MESENCHYMAL STEM CELL; METHYLTRANSFERASES; PROMOTER REGION; TUMORIGENESIS; TUMORIGENICITY;

CALCIUM COMPOUNDS;

5 AZA 2' DEOXYCYTIDINE; ANDROGEN RECEPTOR; DNA METHYLTRANSFERASE; METHYL CPG BINDING PROTEIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL RENEWAL; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EMBRYO; EMBRYONIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROSTATE STEM CELL; STEM CELL; TUMOR XENOGRAFT;

EID: 84869204649     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.AAC120.016615     Document Type: Erratum

References (62)

1. Goldring, M. B., and Marcu, K. B. (2012) Epigenomic and microRNA-mediated regulation in cartilage development, homeostasis, and osteoarthritis. Trends Mol. Med. 18, 109-118
2. Thibault, A., Figg, W. D., Bergan, R. C., Lush, R. M., Myers, C. E., Tompkins, A., Reed, E., and Samid, D. (1998) A phase II study of 5-aza-2′deoxycytidine (decitabine) in hormone-independent metastatic (D2) prostate cancer. Tumori 84, 87-89 (Pubitemid 28221854)
3. Ramos, K. S., Montoya-Durango, D. E., Teneng, I., Nanez, A., and Stribinskis, V. (2011) Epigenetic control of embryonic renal cell differentiation by L1 retrotransposon. Birth Defects Res.AClin. Mol. Teratol. 91, 693-702
4. Wilhelm-Benartzi, C. S., Houseman, E. A., Maccani, M. A., Poage, G. M., Koestler, D. C., Langevin, S. M., Gagne, L. A., Banister, C., Padbury, J. F., and Marsit, C. J. (2011) In utero exposures, infant growth, and DNA-methylation of repetitive element and developmentally related genes in human placenta. Environ. Health Perspect. 120, 296-302
5. Martino, D. J., Tulic, M. K., Gordon, L., Hodder, M., Richman, T. R., Metcalfe, J., Prescott, S. L., and Saffery, R. (2011) Evidence for age-related and individual-specific changes in DNA methylation profile of mononuclear cells during early immune development in humans. Epigenetics 6, 1085-1094
6. Blanco, S., Kurowski, A., Nichols, J., Watt, F. M., Benitah, S. A., and Frye, M. (2011) The RNA-methyltransferase Misu (NSun2) poises epidermal stem cells to differentiate. PLoS Genet. 7, e1002403
7. Wrzeszczynski, K. O., Varadan, V., Byrnes, J., Lum, E., Kamalakaran, S., Levine, D. A., Dimitrova, N., Zhang, M. Q., and Lucito, R. (2011) Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer. PLoS One 6, e28503
8. Kontic, M., Stojsic, J., Jovanovic, D., Bunjevacki, V., Ognjanovic, S., Kuriger, J., Puumala, S., and Nelson, H. H. (2012) Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathologic characteristics of primary non-small-cell lung carcinoma. Clin. Lung Cancer 13, 297-303
9. Trowbridge, J. J., and Orkin, S. H. (2012) Dnmt3a silences hematopoietic stem cell self-renewal. Nat. Genet. 44, 13-14
10. Challen, G. A., Sun, D., Jeong, M., Luo, M., Jelinek, J., Berg, J. S., Bock, C., Vasanthakumar, A., Gu, H., Xi, Y., Liang, S., Lu, Y., Darlington, G. J., Meissner, A., Issa, J. P., Godley, L. A., Li, W., and Goodell, M. A. (2012) Dnmt3a is essential for hematopoietic stem cell differentiation. Nat. Genet. 44, 23-31
11. Mohamed Ariff, I., Mitra, A., and Basu, A. (2012) Epigenetic regulation of self-renewal and fate determination in neural stem cells. J. Neurosci. Res. 90, 529-539
12. Jung, C. J., Iyengar, S., Blahnik, K. R., Ajuha, T. P., Jiang, J. X., Farnham, P. J., and Zern, M. (2011) Epigenetic modulation of miR-122 facilitates human embryonic stem cell self-renewal and hepatocellular carcinoma proliferation. PLoS One 6, e27740
13. Rajasekhar, V. K., Studer, L., Gerald, W., Socci, N. D., and Scher, H. I. (2011) Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling. Nat. Commun. 2, 162
14. Crocoll, A., Zhu, C. C., Cato, A. C., and Blum, M. (1998) Expression of androgen receptor mRNA during mouse embryogenesis. Mech. Dev. 72, 175-178 (Pubitemid 28186717)
15. van Leenders, G. J., and Schalken, J. A. (2001) Stem cell differentiation within the human prostate epithelium: implications for prostate carcinogenesis. BJU Int. 88, Suppl. 2, 35-42; discussion 49-50
16. Heer, R., Robson, C. N., Shenton, B. K., and Leung, H. Y. (2007) The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population. J. Cell Physiol. 212, 572-578 (Pubitemid 47267526)
17. Miki, J., Furusato, B., Li, H., Gu, Y., Takahashi, H., Egawa, S., Sesterhenn, I. A., McLeod, D. G., Srivastava, S., and Rhim, J. S. (2007) Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res. 67, 3153-3161 (Pubitemid 46724852)
18. Isaacs, J. T. (2008) Prostate stem cells and benign prostatic hyperplasia. Prostate 68, 1025-1034
19. Yu, S., Zhang, C., Lin, C. C., Niu, Y., Lai, K. P., Chang, H. C., Yeh, S. D., Chang, C., and Yeh, S. (2011) Altered prostate epithelial development and IGF-1 signal in mice lacking the androgen receptor in stromal smooth muscle cells. Prostate 71, 517-524
20. Cunha, G. R., Alarid, E. T., Turner, T., Donjacour, A. A., Boutin, E. L., and Foster, B. A. (1992) Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions, and growth factors. J. Androl. 13, 465-475
21. Wu, C. T., Altuwaijri, S., Ricke, W. A., Huang, S. P., Yeh, S., Zhang, C., Niu, Y., Tsai, M. Y., and Chang, C. (2007) Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor. Proc. Natl. Acad. Sci. U.S.A. 104, 12679-12684 (Pubitemid 47255214)
22. Cooke, P. S., Young, P., and Cunha, G. R. (1991) Androgen receptor expression in developing male reproductive organs. Endocrinology 128, 2867-2873
23. Kinoshita, H., Shi, Y., Sandefur, C., Meisner, L. F., Chang, C., Choon, A., Reznikoff, C. R., Bova, G. S., Friedl, A., and Jarrard, D. F. (2000) Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer. Cancer Res. 60, 3623-3630 (Pubitemid 30482185)
24. Maitland, N. J., and Collins, A. T. (2008) Prostate cancer stem cells. A new target for therapy. J. Clin. Oncol. 26, 2862-2870
25. Mueller, M. T., Hermann, P. C., and Heeschen, C. (2010) Cancer stem cells as new therapeutic target to prevent tumour progression and metastasis. Front. Biosci. (Elite Ed.) 2, 602-613
26. Klarmann, G. J., Hurt, E. M., Mathews, L. A., Zhang, X., Duhagon, M. A., Mistree, T., Thomas, S. B., and Farrar, W. L. (2009) Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature. Clin. Exp. Metastasis 26, 433-446
27. Xin, L., Lukacs, R. U., Lawson, D. A., Cheng, D., and Witte, O. N. (2007) Self-renewal and multilineage differentiation in vitro from murine prostate stem cells. Stem Cells 25, 2760-2769 (Pubitemid 350127860)
28. Chang, C. Y., Hsuuw, Y. D., Huang, F. J., Shyr, C. R., Chang, S. Y., Huang, C. K., Kang, H. Y., and Huang, K. E. (2006) Androgenic and antiandrogenic effects and expression of androgen receptor in mouse embryonic stem cells. Fertil. Steril. 85, Suppl. 1, 1195-1203
29. Diduch, D. R., Coe, M. R., Joyner, C., Owen, M. E., and Balian, G. (1993) Two cell lines from bone marrow that differ in terms of collagen synthesis, osteogenic characteristics, and matrix mineralization. J. Bone Joint Surg. Am. 75, 92-105 (Pubitemid 23064106)
30. Juffroy, O., Noël, D., Delanoye, A., Viltart, O., Wolowczuk, I., and Verwaerde, C. (2009) Subcutaneous graft of D1 mouse mesenchymal stem cells leads to the formation of a bone-like structure. Differentiation 78, 223-231
31. Jiang, M., Fernandez, S., Jerome, W. G., He, Y., Yu, X., Cai, H., Boone, B., Yi, Y., Magnuson, M. A., Roy-Burman, P., Matusik, R. J., Shappell, S. B., and Hayward, S. W. (2010) Disruption of PPARgamma signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy. Cell Death Differ. 17, 469-481
32. Kawasaki, B. T., Hurt, E. M., Kalathur, M., Duhagon, M. A., Milner, J. A., Kim, Y. S., and Farrar, W. L. (2009) Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells. An integrated molecular profiling approach. Prostate 69, 827-837
33. Duhagon, M. A., Hurt, E. M., Sotelo-Silveira, J. R., Zhang, X., and Farrar, W. L. (2010) Genomic profiling of tumor-initiating prostatospheres. BMC Genomics 11, 324
34. Vander Griend, D. J., Karthaus, W. L., Dalrymple, S., Meeker, A., DeMarzo, A. M., and Isaacs, J. T. (2008) The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res. 68, 9703-9711
35. Mimeault, M., Johansson, S. L., Henichart, J. P., Depreux, P., and Batra, S. K. (2010) Cytotoxic effects induced by docetaxel, gefitinib, and cyclopamine on side population and nonside population cell fractions from human invasive prostate cancer cells. Mol. Cancer Ther. 9, 617-630
36. Tang, D. G., Patrawala, L., Calhoun, T., Bhatia, B., Choy, G., Schneider-Broussard, R., and Jeter, C. (2007) Prostate cancer stem/progenitor cells. Identification, characterization, and implications. Mol. Carcinog. 46, 1-14 (Pubitemid 46095228)
37. Lee, S. O., Ma, Z., Yeh, C. R., Luo, J., Lin, T. H., Lai, K. P., Yamashita, S., Liang, L., Tian, J., Li, L., Jiang, Q., Huang, C. K., Niu, Y., Yeh, S., and Chang, C. (2012) New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs non-stem/progenitor cells. J. Mol Cell Biol., in press
38. Collins, A. T., Berry, P. A., Hyde, C., Stower, M. J., and Maitland, N. J. (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65, 10946-10951 (Pubitemid 41713363)
39. Guzmán-Ramirez, N., Völler, M., Wetterwald, A., Germann, M., Cross, N. A., Rentsch, C. A., Schalken, J., Thalmann, G. N., and Cecchini, M. G. (2009) In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue. Prostate 69, 1683-1693
40. Titus, M. A., Schell, M. J., Lih, F. B., Tomer, K. B., and Mohler, J. L. (2005) Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer. Clin. Cancer Res. 11, 4653-4657 (Pubitemid 41557182)
41. Mishra, D. K., Chen, Z., Wu, Y., Sarkissyan, M., Koeffler, H. P., and Vadgama, J. V. (2010) Global methylation pattern of genes in androgen-sensitive and androgen-independent prostate cancer cells. Mol. Cancer Ther. 9, 33-45
42. Zhao, H., Shiina, H., Greene, K. L., Li, L. C., Tanaka, Y., Kishi, H., Igawa, M., Kane, C. J., Carroll, P., and Dahiya, R. (2005) CpG methylation at promoter site -140 inactivates TGFβ2 receptor gene in prostate cancer. Cancer 104, 44-52 (Pubitemid 40847751)
43. Tilley, W. D., Wilson, C. M., Marcelli, M., and McPhaul, M. J. (1990) Androgen receptor gene expression in human prostate carcinoma cell lines. Cancer Res. 50, 5382-5386 (Pubitemid 20302992)
44. Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., and Baylin, S. B. (1996) Methylation-specific PCR. A novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. U.S.A. 93, 9821-9826 (Pubitemid 26296693)
45. Lin, J., Haffner, M. C., Zhang, Y., Lee, B. H., Brennen, W. N., Britton, J., Kachhap, S. K., Shim, J. S., Liu, J. O., Nelson, W. G., Yegnasubramanian, S., and Carducci, M. A. (2011) Disulfiram is a DNA-demethylating agent and inhibits prostate cancer cell growth. Prostate 71, 333-343
46. Pulukuri, S. M., and Rao, J. S. (2006)CpGisland promoter methylation and silencing of 14-3-3σ gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2. Oncogene 25, 4559-4572 (Pubitemid 44175115)
47. Litvinov, I. V., De Marzo, A. M., and Isaacs, J. T. (2003) Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling? J. Clin. Endocrinol. Metab. 88, 2972-2982 (Pubitemid 36877458)
48. Wang, X., Kruithof-de Julio, M., Economides, K. D., Walker, D., Yu, H., Halili, M. V., Hu, Y. P., Price, S. M., Abate-Shen, C., and Shen, M. M. (2009) A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 461, 495-500
49. Yang, Z., Chang, Y. J., Yu, I. C., Yeh, S., Wu, C. C., Miyamoto, H., Merry, D. E., Sobue, G., Chen, L. M., Chang, S. S., and Chang, C. (2007) ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor. Nat. Med. 13, 348-353 (Pubitemid 46376683)
50. Miyamoto, H., Yang, Z., Chen, Y. T., Ishiguro, H., Uemura, H., Kubota, Y., Nagashima, Y., Chang, Y. J., Hu, Y. C., Tsai, M. Y., Yeh, S., Messing, E. M., and Chang, C. (2007) Promotion of bladder cancer development and progression by androgen receptor signals. J. Natl. Cancer Inst. 99, 558-568 (Pubitemid 47078733)
51. + cell population is enriched in tumor-initiating cells. Cancer Res. 67, 6796-6805
52. Abdallah, B. M., Jensen, C. H., Gutierrez, G., Leslie, R. G., Jensen, T. G., and Kassem, M. (2004) Regulation of human skeletal stem cells differentiation by Dlk1/Pref-1. J. Bone Miner. Res. 19, 841-852 (Pubitemid 41094396)
53. Niakan, K. K., Davis, E. C., Clipsham, R. C., Jiang, M., Dehart, D. B., Sulik, K. K., and McCabe, E. R. (2006) Novel role for the orphan nuclear receptor Dax1 in embryogenesis, different from steroidogenesis. Mol. Genet. Metab. 88, 261-271 (Pubitemid 43963432)
54. Crawford, P. A., Sadovsky, Y., and Milbrandt, J. (1997) Nuclear receptor steroidogenic factor 1 directs embryonic stem cells toward the steroidogenic lineage. Mol. Cell Biol. 17, 3997-4006 (Pubitemid 27281875)
55. Verhagen, A. P., Ramaekers, F. C., Aalders, T. W., Schaafsma, H. E., Debruyne, F. M., and Schalken, J. A. (1992) Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res. 52, 6182-6187
56. 1-integrin expression. J. Cell Sci. 114, 3865-3872
57. Rasheed, Z. A., Kowalski, J., Smith, B. D., and Matsui, W. (2011) Concise review. Emerging concepts in clinical targeting of cancer stem cells. Stem Cells 29, 883-887
58. Li, H., and Tang, D. G. (2011) Prostate cancer stem cells and their potential roles in metastasis. J. Surg. Oncol. 103, 558-562
59. Deonarain, M. P., Kousparou, C. A., and Epenetos, A. A. (2009) Antibodies targeting cancer stem cells. A new paradigm in immunotherapy? MAbs 1, 12-25
60. Sims-Mourtada, J., Izzo, J. G., Ajani, J., and Chao, K. S. (2007) Sonic Hedgehog promotes multiple drug resistance by regulation of drug transport. Oncogene 26, 5674-5679 (Pubitemid 47267845)
61. Dubrovska, A., Elliott, J., Salamone, R. J., Kim, S., Aimone, L. J., Walker, J. R., Watson, J., Sauveur-Michel, M., Garcia-Echeverria, C., Cho, C. Y., Reddy, V. A., and Schultz, P. G. (2010) Combination therapy targeting both tumor-initiating and differentiated cell populations in prostate carcinoma. Clin. Cancer Res. 16, 5692-5702
62. Sonpavde, G., Aparicio, A., Guttierez, I., Boehm, K. A., Hutson, T. E., Berry, W. R., Asmar, L., and von Hoff, D. D. (2007) Phase II study of azacitidine to restore responsiveness of prostate cancer to hormonal therapy. Clin. Genitourin Cancer 5, 457-459 (Pubitemid 351219701)